Cenerimod

DB12705InvestigationalSmall molecule

Cenerimod has been used in trials studying the treatment of Systemic Lupus Erythematosus.

Mechanism: Pharmacologically active on Sphingosine 1-phosphate receptor 1
Curator reviewed
Formula / weight: C₂₅H₃₁N₃O₅ · 453.539 g/mol (avg)
Code names: ACT-334441

Resolves to

Compound

Structure

InChIKeyKJKKMMMRWISKRF-FQEVSTJZSA-NSMILESCCC1=CC(=CC(C)=C1OC[C@@H](O)CO)C1=NOC(=N1)C1=CC(=NC(OC)=C1)C1CCCC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cenerimod, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.